Press • 18.11.2026

"Anna and Her Colourful Circus": Roche and Temedica publish second children's book explaining the symptoms of multiple sclerosis (MS) to children

When Mum has MS: Roche and Temedica explain multiple sclerosis with a colourful circus

Munich, November 2026. Tingling, numbness, fatigue and visual disturbances: many symptoms of multiple sclerosis (MS) cannot be seen from the outside, which makes them particularly hard for children to understand. The new children's book "Anna und ihr kunterbunter Zirkus", jointly published by Roche and Temedica, makes these invisible symptoms tangible for children aged four and up. It was first presented in two booth talks titled "When Mum has MS: explained for children" at the Roche stand at this year's congress of the German Neurological Society (DGN) in Berlin. The response was strong: more than 50 neurologists attended the talks, and all 500 copies of the exclusive advance print were quickly gone.

In the lovingly illustrated story, readers follow little Evi and her mum Anna, who lives with MS. Because Evi is a huge circus fan, she imagines Anna's symptoms as animals in a circus ring: the ants stand for the tingling on the skin, the spider for numb arms, the sleepy koala for fatigue and the mole for the phases when Anna's vision is blurred. The animals come and go, but Anna remains the ringmaster. In this way, the book shows that MS can be part of family life without defining it, and that closeness, shared adventures and laughter still have their place.

"As a neurologist, I know that MS presents differently in everyone. This book makes invisible symptoms tangible and invites parents and children of all ages to ask questions, share feelings and talk to each other about MS. Children should know that it is not their fault. This way, every family can find its own path," says Prof. Dr. med. Christoph Kleinschnitz, Director of the Department of Neurology at University Hospital Essen, who provided medical guidance for the project. In the booth talk, he gave the neurologists present ideas on how to raise the topic with affected families during consultations.

For TV presenter Anna Kraft, the book is a project close to her heart. She has been patron of the trotz ms campaign for almost two years, lives with MS herself and is the mother of two daughters. In the booth talk, she described how she explained the condition to her own children: "When I found out I had MS, I had a thousand questions. One of them was: how do I explain it to my children? What you can't see is hard to understand. This book is meant to encourage children to ask questions, because it is okay to talk about illness. And above all, I want to show that a mum or dad with MS is so much more than this disease."

The close collaboration between Prof. Dr. Christoph Kleinschnitz, Anna Kraft, Roche, Temedica and the trotz ms community shows how medicine, digital health and the patient perspective can come together to create accessible educational resources.

"For us at Roche, support does not end with medical therapy. We want to empower patients and their families throughout their everyday lives. The enormous response at the DGN Congress shows how great the need is in practice for accessible, everyday educational resources. With this book, we are building a bridge between medicine and family life together," emphasises Christina Ankirchner, Principal Patient Partnership Lead at Roche Pharma AG.

Dr. Dennis Kwiatkowski of Temedica adds: "With our second children's book, we are going one step further. After the basics of the disease, the focus is now on the symptoms that children experience in everyday life. We want to give families a language that lets them talk about MS openly and without fear."

 

From the congress to families

The publication continues Roche and Temedica's shared mission to strengthen understanding for people with multiple sclerosis and their families. It follows on from the first joint children's book "Paul und die geheimen Wackelkontakte" ("Paul and the Secret Loose Connections"), which was presented at the DGN Congress in 2025 and explains what happens in the body with MS. The new book now turns to everyday life: to the symptoms children notice in their parents, and to how families can deal with them together.

The colourful watercolour illustrations by Kathrin Boll, who also illustrated the first book, connect everyday family life with medical understanding. Their aim is to make conversations about MS easier, gentler and more curious rather than fearful.

DGN2026_Roche_Stand_Kinderbuch.jpg

Availability

"Anna und ihr kunterbunter Zirkus" is available in German only. Following the sold-out advance print at the DGN Congress, the book is now available on request. Copies can be ordered free of charge via info@trotz-ms.de or downloaded as a PDF at trotz-ms.de/service/infomaterialien.

Learn more:



About Roche Germany

Roche employs almost 18,600 people in Germany in its Pharmaceuticals and Diagnostics divisions. Among others, the company operates three major sites in Mannheim, Penzberg and Grenzach-Wyhlen. Its activities span the entire value chain of both divisions, "Pharma" and "Diagnostics": from research and development through production and logistics to marketing and sales, with each site taking on global responsibilities alongside the German business. Roche is firmly committed to its German sites and has invested almost 3.8 billion euros in them since 2020.

For more information on Roche in Germany, please visit roche.de.

For inquiries about the company:

 Faten Gaber   Roche Pharma AG, 
 Head of Communications & Public Affairs    Emil-Barell-Straße 1, 
 grenzach.communications@roche.com   79639 Grenzach-Wyhlen 

 

About Temedica

Temedica is a technology, AI and data-driven company that develops solutions and services for the pharmaceutical industry. Since 2016, Temedica has been supporting pharmaceutical companies in taking their brand performance to a new level through holistic strategies and targeted implementation. With the help of real-world insights, configurable AI-supported solutions and in-depth medical and commercial expertise, Temedica turns go-to-market challenges into measurable success.

Temedica is backed by a consortium of renowned investors with many years of experience in the biopharmaceutical industry, including BioNTech's founding investors. Further information can be found at temedica.com

Press contact: Now available:
Lisa Scharinger Clevi is available free of charge in the app stores. 
pr@temedica.com
More information about the app: WWW.CLEVI-HEALTH.COM
 +49 175 7365791 Learn more about the Omnichannel Patient Engagement Suite: WWW.TEMEDICA.COM

 

Stay informed on new healthcare insights!

Subscribe to our newsletter and never miss out on the latest advancements, insights, and events.

Want to enable your commercial teams with real-world insights?